login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
TEMPUS AI INC (TEM) Stock News
NASDAQ:TEM -
US88023B1035
-
Common Stock
79.62
USD
+1.5 (+1.92%)
Last: 9/5/2025, 8:00:01 PM
79.71
USD
+0.09 (+0.11%)
Pre-Market:
9/8/2025, 5:24:49 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
TEM Latest News, Press Relases and Analysis
All
Press Releases
4 minutes ago - By: Chartmill
TEMPUS AI INC (NASDAQ:TEM) Excels on Minervini Trend Template with High Growth Momentum
4 days ago - By: Zacks Investment Research
- Mentions:
EXAS
GH
What's Fueling Tempus AI's Q2 Net Loss Improvement Momentum?
4 days ago - By: Tempus AI, Inc.
Northwestern Medicine Becomes First Health System to Integrate Tempus’ Generative AI Co-Pilot, David, Into Its EHR Platform
5 days ago - By: Tempus AI, Inc.
Tempus to Participate in Morgan Stanley’s 23rd Annual Global Healthcare Conference
5 days ago - By: Benzinga
- Mentions:
ASO
ACN
BWA
UIS
...
This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
6 days ago - By: MarketBeat
- Mentions:
RIVN
MP
TSLA
LI
3 Heavily Shorted Stocks That Could Prove the Bears Wrong
6 days ago - By: Benzinga
Forecasting The Future: 5 Analyst Projections For Tempus AI
9 days ago - By: Yahoo Finance
- Mentions:
MSFT
HOOD
Tempus AI, Inc. (TEM) Expands into Digital Pathology with Paige Acquisition
12 days ago - By: Zacks Investment Research
- Mentions:
TDOC
HIMS
Hims & Hers Scales Growth Through Subscriptions and Care Expansion
13 days ago - By: Zacks Investment Research
- Mentions:
NEO
VCYT
Tempus' Key Acquisitions Strengthen Its AI Healthcare Leadership
13 days ago - By: Yahoo Finance
- Mentions:
MSFT
DGX
Tempus inks $81M Paige buyout to support AI model development
14 days ago - By: Zacks Investment Research
- Mentions:
AZN
NVDA
BFLY
Tempus AI or Butterfly: Which AI Health Tech Stock is a Buy Now?
16 days ago - By: The Motley Fool
- Mentions:
RXRX
NVDA
TM
The Next Big Thing: 2 AI-Powered Healthcare Stocks Ready to Explode
17 days ago - By: Yahoo Finance
- Mentions:
MSFT
Tempus AI Expands Into Digital Pathology With Paige Acquisition
17 days ago - By: Tempus AI, Inc.
Tempus Announces the Acquisition of Paige
17 days ago - By: Zacks Investment Research
- Mentions:
BSX
JNJ
GEHC
4 Medical Devices Behemoths to Buy Amid Extensive AI Applications
17 days ago - By: Zacks Investment Research
- Mentions:
TSLA
PLTR
HOOD
Cathie Wood's ARKK ETF is Back: Buy It or Not?
19 days ago - By: MarketBeat
- Mentions:
SMR
SYM
ASTS
SOUN
5 High Short-Interest Stocks to Buy Before November
20 days ago - By: Zacks Investment Research
- Mentions:
AZN
ABBV
SOPH
Strategic Partnerships Power Tempus AI's Healthcare Expansion
24 days ago - By: Bragar Eagel & Squire
TEMPUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Tempus AI, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
26 days ago - By: Zacks Investment Research
- Mentions:
IRTC
SOPH
Tempus AI Stock Jumps Post Q2 as EBITDA Breakeven Nears: Buy or Hold?
26 days ago - By: Zacks Investment Research
- Mentions:
EXAS
GH
TEM Once Again Raises Its 2025 Sales Guidance: What's Driving the Move?
Please enable JavaScript to continue using this application.